ADMA Biologics Inc (ADMA)

Last Closing Price: 15.70 (2026-03-05)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ADMA Biologics Inc (ADMA) had Net Income of $146.93M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$510.17M
Net Income
$146.93M
$217.41M
$292.76M
$318.73M
$191.44M
$-8.79M
$182.66M
$182.66M
$146.93M
$146.93M
$146.93M
$146.93M
$191.44M
$200.11M
238.30M
244.91M
$0.62
$0.60
Balance Sheet Financials
$466.51M
$65.06M
$157.73M
$624.24M
$69.54M
$75.98M
$77.38M
$146.92M
$477.32M
$473.16M
$477.32M
237.87M
Cash Flow Statement Financials
$50.40M
$-21.89M
$-44.02M
$103.15M
$87.63M
$-15.52M
$20.03M
--
--
Fundamental Metrics & Ratios
6.71
--
--
0.14
0.17
57.39%
37.53%
37.53%
39.22%
35.80%
28.80%
$27.82M
--
--
--
0.82
1.05
3.22
113.35
30.78%
31.05%
23.54%
26.56%
$2.01
$0.11
$0.21